Earlier, the company of the biotech company Emergent BioSolution accidentally mixed the ingredients for two vaccines-AstraZeneca and Johnson & Johnson. As a result, 15 million doses were spoiled.
According to the publication, now the plant will produce only a single-component Johnson & Johnson vaccine. AstraZeneca, in turn, said that it would discuss with the US authorities an alternative version of the production of its drug.
Earlier, some European countries suspended using the AstraZeneca vaccine due to reports of thromboembolic complications in vaccinated patients. The European Medicines Agency (EMA) investigated the incidents.